Antibiotic-Associated Colitis
7
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis
A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
Response of Clostridium Difficile Infection to Metronidazole Therapy
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea